LUXI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.411
EU - Europa 940
AS - Asia 731
SA - Sud America 108
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 1
Totale 3.318
Nazione #
US - Stati Uniti d'America 1.309
RU - Federazione Russa 502
SG - Singapore 359
IT - Italia 197
CN - Cina 106
BR - Brasile 76
HK - Hong Kong 75
VN - Vietnam 75
CA - Canada 73
GB - Regno Unito 58
DE - Germania 41
FR - Francia 29
FI - Finlandia 27
IN - India 27
KR - Corea 23
IE - Irlanda 19
SE - Svezia 18
BD - Bangladesh 14
BJ - Benin 14
NG - Nigeria 12
TG - Togo 12
ZA - Sudafrica 12
AR - Argentina 10
NL - Olanda 10
AT - Austria 9
JP - Giappone 9
TR - Turchia 9
MX - Messico 8
PL - Polonia 8
CO - Colombia 7
IL - Israele 7
ES - Italia 6
CR - Costa Rica 5
SC - Seychelles 5
CL - Cile 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
NI - Nicaragua 4
PR - Porto Rico 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UZ - Uzbekistan 3
EE - Estonia 2
EG - Egitto 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VE - Venezuela 1
YE - Yemen 1
Totale 3.256
Città #
Dallas 233
Singapore 231
Ashburn 205
Moscow 166
San Jose 164
Verona 81
Hong Kong 74
Chandler 40
Council Bluffs 38
Los Angeles 37
Ho Chi Minh City 28
New York 28
Toronto 27
Beijing 24
London 23
The Dalles 22
Santa Clara 18
Helsinki 17
Dublin 16
Milan 16
Phoenix 16
Buffalo 14
Cotonou 14
São Paulo 14
Hamilton 13
Lomé 12
Montreal 12
Abuja 11
Hanoi 11
Johannesburg 11
Rome 11
Seattle 11
Atlanta 10
Amsterdam 9
Brooklyn 9
Catania 9
Tokyo 9
Boardman 8
Chennai 8
Da Nang 8
Denver 8
Orem 8
Poplar 8
Chicago 7
Hyderabad 7
North Bergen 7
North Hollywood 7
Boydton 6
Misterbianco 6
Redondo Beach 6
Seoul 6
Chions 5
Columbus 5
Falkenstein 5
Houston 5
McKinney 5
Munich 5
Nuremberg 5
Philadelphia 5
Princeton 5
San Francisco 5
Southend 5
Stockholm 5
Warsaw 5
Ankara 4
Cincinnati 4
Cleveland 4
Lawrence 4
Madrid 4
Managua 4
Monserrato 4
Mumbai 4
Naples 4
Redmond 4
San José 4
Bonavigo 3
Calgary 3
Frankfurt am Main 3
Guangzhou 3
Jakarta 3
Lappeenranta 3
Manchester 3
Mexico City 3
Milford 3
Newark 3
Palermo 3
Piscataway 3
Roubaix 3
San Salvador 3
Sindelfingen 3
Tashkent 3
Turku 3
Vicenza 3
Vienna 3
Washington 3
Wroclaw 3
Annandale 2
Baghdad 2
Belo Horizonte 2
Bengaluru 2
Totale 1.964
Nome #
Safety Profile of Antiviral Therapies for the Early Treatment/Prevention of COVID-19: Analysis of the International Pharmacovigilance Database VigiBase 237
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 224
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 224
Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies 202
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study 173
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBase 166
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 153
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study 149
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System 148
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 146
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 144
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 140
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study 138
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports 133
Anaphylaxis due to antiallergic and antiasthmatic biologics 131
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database 131
Terapia immunosoppressiva di mantenimento nei pazienti sottoposti a trapianto di organo solido: survey delle esperienze dai centri-trapianto italiani 120
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study 116
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase® 110
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” 98
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose 94
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women 59
Monitoraggio della sicurezza dei vaccini COVID-19 in popolazioni speciali attraverso sistemi di farmacovigilanza attiva: risultati del progetto europeo Covid-Vaccine-Monitor 34
Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase 29
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study 19
Totale 3.318
Categoria #
all - tutte 11.208
article - articoli 10.637
book - libri 0
conference - conferenze 362
curatela - curatele 0
other - altro 209
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 13 2 2 1 1 0 2 14
2022/2023142 14 14 6 23 2 24 0 12 15 5 20 7
2023/2024171 4 21 13 12 13 22 10 11 7 24 17 17
2024/2025506 30 14 47 85 21 33 15 16 81 41 51 72
2025/20261.903 92 169 172 309 485 116 196 105 87 116 30 26
2026/2027552 40 78 118 255 61 0 0 0 0 0 0 0
Totale 3.318